Exploration of quantitative structure activity relationship studies on a series of substituted quinazolinones as angiotensin II AT1 receptor antagonists

World Applied Sciences Journal

Volumn 12, Issue 11, 2011, Pages 2111-2119

  Sharma, Mukesh Chandra ^a   Kohli, Dharm Veer ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Ang II; Antihypertensive; AT1; QSAR; Quinazolinones

Indexed keywords

EID: 84866434655     PISSN: 18184952     EISSN: 19916426     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ferrario, C.M., 1990. The Renin-Angiotensin System: Importance in Physiology and Pathology. J. Cardiovasc. Pharmacol., 15(3): 51-55.
2. Khosla, S.C. and C.D. Withdraw, 1990. Remington's Pharmaceutical Sciences. Me. Pub. Co.
3. Vallotton, M.B., 1987. The Renin-Angiotensin System. Trends. Pharmacol. Sci., 8: 69.
4. Nahmias, C. and A.D. Strosberg, 1995. The angiotensin AT2 Receptor Searching for Signal-Transduction Pathways and Physiological Function. Trends. Pharmacol. Sci., 16: 223-225.
5. Berecek, K.H., S.J. Kmg and J.N. Wu, 1993. Angiotensin-Converting Enzyme and Converting Enzyme Inhibitors. Cellular and Molecular Biology of the Renin-Angiotensin System; CRC Press: Boca Raton, FL, pp: 183-220.
6. Kleinert, H.D., 1994. Recent Developments in Renin Inhibitors. Exp. Opin. Invest. Drugs., 3: 1087-1104.
7. Furukawa, Y., S. Kishimoto andK. Nishikawa, 1982. U.S. Patent 4340598.
8. Carini, D.J., J.V. Duncia, P.E. Aldrich, A.T. Chiu, A.L. Johnson, M.E. Pierce, et al., 1991. Nonpeptide Angiotensin II Receptor Antagonists: The Discovery of a Series of N-(Biphenyl methyl)imidazoles as Potent, Orally Active Antihypertensive. J. Med. Chem., 34: 2525-2547.
9. Kubinyi, H., R. Mannhold, L.R. Krogsgaard and H. E. Timmerman, 1993. Methods and principles in medicinal chemistry, 1. VCH, Weinheim.
10. Belvisi, L., G. Bravi, G. Catalano, M. Mabiliab, A. Salimbeni and C. Scolastico, 1996. A 3D QSAR CoMFA study of nonpeptide angiotensin II receptor antagonists. J. Comput. Aided. Mol. Des., 10: 567-582.
11. Sharma M.C., S. Sharma, N.K. Sahu and D.V. Kohli, 2011. QSAR Studies of some Substituted imidazolinones Derivatives angiotensin II receptor antagonists using Partial Least Squares Regression (PLSR) Based Feature Selection. J. Saud. Chem. Soc. (In press).
12. Sharma, M.C., S. Sharma, N.K. Sahu and D.V. Kohli, 2011. 3D QSAR kNNMFA studies on 6-Substituted Benzimidazoles Derivatives As Nonpeptide Angiotensin II Receptor Antagonists: A Rational Approach to antihypertensive agents Journal of Saudi Chemical Society (In press).
13. Sharma, M.C., D.V. Kohli, S.C. Chaturvedi and S. Sharma, 2009. Molecular Modeling Studies of Some substituted 2-butylbenzimidazoles angiotensin II receptor antagonists as antihypertensive agents. Digest. J. Nanomat. Biostruct., 4(4): 843-856.
14. Yoo, S.E., S.K. Kim, S.H. Lee, K. Y. Yi and D.W. Lee, 1999. A comparative molecular field analysis and molecular modeling studies on pyridylimidazole type of angiotensin II antagonists. Bioorg. Med. Chem., 7: 2971-2976.
15. Pandya, T. and S.C. Chaturvedi, 2004. QSAR study of a series of 2, 3,6-substituted quinazolinones as ATI selective angiotensin II receptor antagonists. Ind. J. Chem., 43B(11): 2440-2445.
16. Levin, J.I., A.M. Venkatesan, P. S. Chan, J.S. Baker, T.K. Bailey, G. Vice, G. Francisco, A. Katocs, F. lai and J. Coupet, 1994. 2, 3, 6-Substituted Quinazolinones as Angiotensin II Receptor Antagonists. Bioorg. Med. Chem. Lett., 4(9): 1135-1140.
17. Vlife MDS software package, version 3.5, supplied by Vlife science technologies Pvt. Ltd, 1, Akshay 50, Anand park, Aundh, Pune, India 411007.
18. Halgren, T.A., 1996. Merck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94. J. Comput. Chem., 17: 553-586.
19. Golbraikh, A. and A. Tropsha, 2002. Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. J. Comp. Aided. Mol. Design., 16: 357-369
20. Cramer, R.D., D.E. Patterson and J.D. Bunce, 1988. Comparative molecular field analysis (CoMFA) 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc., 110: 5959-67.
21. Zheng, W. and A. Tropsha, 2000. Novel variable selection quantitative structure-property relationship approach based on the knearest-neighbor principle. J. Chem. Inf. Comput. Sci., 40: 185-194.
22. Guyon, I. and A. Elisseeff, 2003. An introduction to variable and feature selection. J. Mach. Learning. Res., 3: 1157-1182.
23. Wold, S., 1995. PLS for multivariate linear modeling. H. Vande Waterbeemd, Ed.; VCH, Weinheim, pp: 195-218.
24. Kulkami, S. S. and V.M. Kulkami, 1999. Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: a comparative molecular field analysis study. J. Med. Chem., 42: 373-380.
25. Sharma, M.C. and S. Sharma, 2010. D-Quantitative Structure-Activity Relationship Analysis of Some 2-Substituted Halogen benzimidazoles Analogues with Antimycobacterial activity. Int. J. Chem. Tech. Res., 2(1): 606-614.
26. Sharma, M.C., S. Sharma, D.V. Kohli and S.C. Chaturvedi, 2010. Three Dimensional Quantitative Structural-Activity Relationship (3D-QSAR) Studies some 3-{4-[3-(2-aryl-phenoxy) butoxy]-phenyl} Propionic acids as novel PPAR γ/δ agonists. Der. Pharma. Chemica., 2(1): 82-90.
27. Sharma, M.C., S. Sharma, D.V. Kohli and S.C. Chaturvedi, 2010. QSAR and k-Nearest Neighbour Molecular Field Analysis (k-NN MFA) Classification Analysis of Studies of Some Bemzimidazoles Derivatives Antibacterial activity Against Escherichia coli. Der. Pharmacia. Lettr., 2(1): 150-161.
28. Nandi, S. and M.C. Bagchi, 2010. 3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: a rational approach to anticancer drug design. Mol. Divers., 14: 27-38.